Angelo Baldassarre C.
- Country
- Italy
- Department
- NA
Research Overview
- Evaluation of Obicetrapib on Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients on Maximal Lipid-Modifying Therapy
- Evaluation of ISIS 678354 Sodium Salt in Patients with Severe Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
- A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk
Data & Insights
Has run more than one trial at 246 of 739 partner sites.
Specializations
Cardiovascular Research
This investigator specializes in studying hypertriglyceridemia and its relationship to cardiovascular health, with particular emphasis on managing elevated triglyceride levels in patients with atherosclerotic cardiovascular disease.
- Lipid Management
- Cardiovascular Risk Reduction
- Atherosclerosis Treatment
The research focuses on innovative therapeutic approaches for patients with severe lipid disorders affecting cardiovascular health.
Metabolic Disorders
The investigator concentrates on understanding and treating severe hypertriglyceridemia, exploring new therapeutic interventions for patients with significant triglyceride elevation.
- Triglyceride Level Management
- Metabolic Disease Treatment
- Lipid Disorder Therapy
Their work encompasses the evaluation of novel treatments for patients with complex metabolic conditions affecting lipid metabolism.
Preventive Cardiology
The investigator's work extends to preventive cardiology, focusing on managing cardiovascular risk factors through lipid modification and innovative therapeutic approaches.
- Cardiovascular Prevention
- Risk Factor Management
- Therapeutic Innovation
Their research aims to advance treatment options for patients with combined cardiovascular and metabolic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.